Pacer Advisors
JAZZ icon

Pacer Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pacer Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2M Sell
146,264
-356,749
-71% -$78.2M 0.09% 240
2026
Q1 		$95.1M Sell
503,013
-144,071
-22% -$25.2M 0.27% 88
2025
Q4 		$110M Buy
647,084
+107,144
+20% +$16.4M 0.28% 76
2025
Q3 		$71.2M Sell
539,940
-194,639
-26% -$23.3M 0.18% 131
2025
Q2 		$78M Sell
734,579
-110,126
-13% -$12M 0.19% 111
2025
Q1 		$105M Sell
844,705
-1,369,775
-62% -$179M 0.25% 84
2024
Q4 		$273M Buy
2,214,480
+115,102
+5% +$13.6M 0.59% 41
2024
Q3 		$234M Buy
2,099,378
+278,465
+15% +$30.5M 0.49% 51
2024
Q2 		$194M Buy
1,820,913
+527,187
+41% +$58M 0.44% 53
2024
Q1 		$156M Buy
1,293,726
+270,020
+26% +$33.1M 0.36% 85
2023
Q4 		$126M Buy
1,023,706
+224,865
+28% +$28.1M 0.36% 76
2023
Q3 		$103M Buy
798,841
+114,552
+17% +$15.3M 0.4% 61
2023
Q2 		$84.8M Buy
684,289
+206,243
+43% +$27.7M 0.34% 64
2023
Q1 		$70M Buy
478,046
+137,586
+40% +$20.4M 0.3% 76
2022
Q4 		$54.2M Buy
340,460
+337,685
+12,169% +$49.5M 0.28% 70
2022
Q3 		$370K Buy
+2,775
New +$422K ﹤0.01% 1023
2022
Q1 		– Sell
-6,260
Closed -$798K – 2414
2021
Q4 		$798K Sell
6,260
-463
-7% -$60.8K 0.01% 1339
2021
Q3 		$875K Sell
6,723
-16,149
-71% -$2.44M 0.01% 931
2021
Q2 		$4.06M Buy
22,872
+16,567
+263% +$2.87M 0.06% 417
2021
Q1 		$1.04M Buy
6,305
+239
+4% +$39.3K 0.02% 759
2020
Q4 		$1M Buy
+6,066
New +$903K 0.02% 696

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Pacer Advisors's JAZZ Position: Q2 2026 in Review

Pacer Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 71% in Q2 2026, selling an estimated $78.2M and leaving 146,264 shares worth $35.2M. The position accounts for 0.09% of the portfolio, ranked #240.

Pacer Advisors first reported a position in JAZZ in Q4 2020 and has held it in 21 quarters since. The position peaked at $273M in Q4 2024. 645 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Pacer Advisors held 146,264 shares of Jazz Pharmaceuticals worth $35.2M as of Q2 2026.
  • Pacer Advisors sold 356,749 Jazz Pharmaceuticals shares in Q2 2026, an estimated $78.2M.
  • Jazz Pharmaceuticals made up 0.09% of Pacer Advisors's portfolio in Q2 2026, its #240 holding.
  • Pacer Advisors first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Pacer Advisors's Jazz Pharmaceuticals position peaked at $273M in Q4 2024.
  • 645 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.